Clinical trial · Interventional
Clasic Laryngeal Mask Airway(C-LMA) and I-gel Releated Regurgitation and Complications
Comparation the Effect of C-LMA and I-gel in Regurgitation and Postoperative Complications
NCT01876836CI-TRIAL-00010714C-LMAunknownPhase 4ClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
1. i-gel 2. C-LMA Compare the effect on gastroeosephageal reflux Postoperative complicatios.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Bladder Tumour | Bladder Neoplasm | ALIAS | 0.90 |
| Prostate Hyperplasia | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| C-LMA | Device | — | UNRESOLVED |
| i-gel | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- i-gel
- description
- i-gel placed after induction
- interventionNames
- Device: i-gel
- type
- ACTIVE_COMPARATOR
- label
- C-LMA
- description
- C-LMA placed after induction
- interventionNames
- Device: C-LMA
Primary outcomes (1)
- measure
- Ph MEASUREMENT
- timeFrame
- 1 MİNUTE AFTER EXTUBATİON
- description
- The ph of the secretions on the airway device will be measurd with a Ph-meter
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 19 Years
- Maximum age
- 70 Years
Show eligibility criteria text
Inclusion Criteria: * ASA I-II * Adult * Elective surgery * Bladder tumour * Prostat hyperplasi Exclusion Criteria: * Emergency surgery * Hiatal hernia * Gastroeosephageal reflux disease
References
Publications (0)
Data not yet available
No reference posted for this study.